Stay updated on Nivolumab and Cyclophosphamide for R/R AML Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.

Latest updates to the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe revision tag on the page was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed in the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision: v3.4.1 was added. The notices about government funding lapse and the previous Revision: v3.4.0 were removed.SummaryDifference0.4%

- Check80 days agoChange DetectedThe page now shows a glossary and adds QC-related metadata labels ('Last Update Submitted that Met QC Criteria') along with a revision note ('Revision: v3.4.0'), while older QC label, no-FEAR Act data note, and the prior revision label ('v3.3.4') were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check87 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Cyclophosphamide for R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.